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Abstract
Arthritis is the most common chronic health condition in Canada, with the most common
form being osteoarthritis (OA). There is a great clinical need for an objective imagingbased point-of-care tool to assess OA status, progression, and response to treatment. This
thesis aims to validate a handheld mechanical three-dimensional (3D) ultrasound (US)
device against the current clinical standard of magnetic resonance imaging (MRI) for
quantifying femoral articular cartilage (FAC) volume. Knee images of 25 healthy
volunteers were acquired using 3D US and 3.0 Tesla MRI scans. Two raters manually
segmented the trochlear FAC during separate sessions to assess intra- and inter-rater
reliabilities. The results demonstrated that 3D US has excellent reliability and strong
concurrent validity with MRI for measuring healthy FAC volume. 3D US is a promising,
inexpensive, and widely accessible imaging modality that will enable clinicians and
researchers to obtain additional information without added complexity or discomfort to
patients.

Keywords
Three-dimensional ultrasound, knee arthritis, cartilage, osteoarthritis, MRI, validation,
reliability, segmentation, image processing
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Summary for Lay Audience
Arthritis is the most common disease in Canada, affecting around 21% of the population.
There are over 100 different types of arthritis, with the most common type being
osteoarthritis (OA). Medical imaging systems such as x-ray imaging and magnetic
resonance imaging (MRI) are utilized to diagnose and monitor OA by taking pictures of
joints such as the knee. Structures within the knee joint are observed to assess disease
progression and response to treatment. While x-ray imaging is excellent at visualizing
bone, it cannot visualize soft tissues such as cartilage, ligaments, and fat. It is challenging
to use x-ray imaging to assess cartilage abnormalities caused by OA. MRI is excellent at
visualizing soft tissues, but MRI systems are expensive to operate and have long waitlists
and imaging times. Furthermore, neither x-ray imaging nor MRI can be used to acquire
images at the patient’s bedside. There is a tremendous clinical need for an imaging
system that can assess knee cartilage at the patient’s bedside without the limitations of xray and MRI. This work aimed to use 3D ultrasound (US) imaging to meet this clinical
need and compare it against MRI for measuring knee cartilage volume.
Knee images of 25 healthy volunteers were acquired using MRI and 3D US. Two raters
traced the cartilage from MRI and 3D US images to measure the cartilage volume. The
cartilage was traced multiple times to assess the reliability of each rater. The cartilage
volumes were compared between MRI and 3D US to evaluate the performance of 3D US
against the current clinical standard of MRI. The results demonstrated that clinicians and
researchers could use 3D US to measure knee cartilage volume at the patient’s bedside
with excellent reliability and strong agreement with MRI. 3D US is a promising,
inexpensive, and widely accessible imaging modality that will enable clinicians and
researchers to measure knee cartilage volume without the limitations of x-ray and MRI.
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Chapter 1
1

Introduction

Medical imaging has advanced drastically since the discovery of x-rays in 1895 by
Wilhelm Rӧntgen. Currently, radiologists are capable of observing the human body with
magnificent detail through the use of x-ray radiography, computed tomography (CT),
magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound
(US), and various other modalities.1 Medical imaging has had significant positive impacts
on diagnosing, monitoring, and treating various diseases. As technologies continue to
improve, new imaging modalities are being developed to overcome challenges in
visualizing the human body and treating various diseases. However, with the growth of
medical imaging, concerns over radiation risks, high manufacturing and operating costs,
and accessibility to many patients have intensified.2 It is vital to keep these concerns in
mind when developing new modalities to increase their accessibility and effectiveness for
disease diagnosis and monitoring.
Diagnosing and monitoring musculoskeletal diseases can be accomplished with medical
imaging using x-ray radiography, MRI, and US. However, these methods are associated
with limitations in sensitivity and accuracy when assessing musculoskeletal diseases such
as arthritis.3 Therefore, there is an unmet clinical need for a new imaging tool to directly
visualize musculoskeletal disease pathology for assisting in diagnosis and monitoring
response to therapy. Three-dimensional (3D) US imaging is a relatively new modality
that can meet this clinical need and overcome the limitations of x-ray radiography, MRI,
and conventional US. This thesis will explore the application of handheld 3D US imaging
as a lower-cost imaging modality to provide clinicians and researchers with the ability to
monitor arthritis progression and response to treatment. This thesis will specifically
investigate the application of 3D US imaging to monitor knee arthritis progression, but
3D US techniques have been applied to other areas such as neonatal, gynecological, and
vascular applications, among others.4,5,6 3D US imaging has the potential to alter the
workflow of orthopedic, sports medicine, primary care, and arthritis clinics by enabling
bedside disease monitoring. The remainder of this chapter provides a background on knee
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arthritis and current methods of diagnosis, treatment, and monitoring. It also outlines the
underlying principles of 3D US imaging and medical image processing techniques and
describes the unmet needs, hypothesis, and specific objectives of this thesis.

1.1

Knee osteoarthritis

Arthritis is the most common chronic health condition in Canada, affecting
approximately 21% of the population.7 There are over 100 different forms of arthritis,
including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and other
inflammatory forms.8 The most common form of arthritis is osteoarthritis (OA) which
was previously thought to be caused by the “wear and tear” of joint tissues such as
cartilage and the underlying bone. However, OA is a whole-joint disease and is described
as an abnormal remodelling of joint tissues caused by a host of inflammatory agents. OA
can affect any joint in the body, with the most common sites being the knee and hip. 9
Patients with OA suffer from debilitating pain, disability, and a decreased quality of
life.10 Furthermore, OA has high comorbidity with other chronic health conditions such
as cardiovascular diseases, diabetes mellitus, and depression.11,12,13,14 The presence of
comorbidities causes higher mortality, increased hospitalization, poor physical and
mental health, and worse disease outcomes.15
Knee OA (KOA) is of particular importance to study because of its high prevalence rate
compared to other types of OA and its appearance earlier in life, specifically in young
obese women.16 The prevalence of KOA is higher for women than men and is higher in
older age groups.17 Females over 55 years tend to experience more severe OA in the knee
joint but not in other sites.18 Furthermore, the prevalence of KOA is increasing with
rising obesity rates and population ageing.19 The impact KOA has on an individual’s
quality of life, and its high prevalence, stresses the need for further research.

1.1.1

Risk factors

A risk factor is a variable associated with an increase in the risk of a particular disease.
Variables that affect the risk of KOA include age, biological sex, congenital joint
abnormalities, history of injury, body mass index (BMI), occupational factors, physical
activity, comorbidities, and more. The prevalence of KOA increases with every decade of
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life, with the highest incidence between 55 and 64 years of age.20 Many studies have
demonstrated consistent evidence that females are at higher risk for KOA than males,
according to biological sex.21 Large areas of cartilage loss can lead to joint malalignment,
which is the most significant risk factor for knee structural degradation due to unequal
focal loading.22 Joint malalignment can also be congenital, increasing the risk of KOA
incidence. Anterior cruciate ligament and meniscal injuries are substantial risk factors for
KOA at ten or more years following injury.23 Studies assessing BMI demonstrated that
being overweight (BMI between 25 and 29.9) or obese (BMI of 30 and over) increases
the risk for KOA.24 OA environmental risk factors such as obesity, joint injury, and joint
overload are primarily mechanical in nature. Studies have shown that muscle weakness,
joint instability, and malalignment may be possible causes of KOA rather than results of
KOA-induced joint damage.25,26 There is some evidence that various occupation-related
movements such as kneeling, squatting, climbing steps, excessive standing, and lifting
increase KOA risk.24 Physical activity is a recommended treatment option for KOA, but
there is mixed evidence, with habitual and high-intensity physical exercise leading to an
increased KOA risk.21,24 In healthy and KOA joints, metabolism plays an essential role in
remodelling various joint tissues.27 Cartilage softening and catabolism have been
observed in patients with diabetes, although there is little evidence to conclude that
impaired glucose metabolism increases KOA risk independent of obesity and age.28,29
Risk factors play an essential role in detecting and preventing KOA.

1.1.2

Knee anatomy

The knee is the largest synovial joint in humans and contains the distal femur, proximal
tibia, patella, meniscus, hyaline cartilage, ligaments, and a synovial membrane.30 KOA
leads to articular cartilage loss of the femur, tibia, and patella. KOA also results in
subchondral bone remodelling, synovial inflammation (synovitis), and periarticular
muscle weakening (Fig. 1).31 Localized cartilage loss increases the stress across the knee
joint, which leads to further cartilage degradation and loss. The limited intrinsic healing
capabilities of the articular cartilage highlight the importance of maintaining joint
health.32
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Figure 1.1 Anatomical diagrams depicting the difference between a normal knee and an
osteoarthritic knee involving articular and periarticular tissues. Reproduced with
permission from Sharma L. Osteoarthritis of the Knee. N Engl J Med. 2021;384:51-59.
Doi:10.1056/NEJMcp1903768, Copyright Massachusetts Medical Society.
Articular cartilage is classified as hyaline cartilage and has an average thickness ranging
between 2 to 4 mm. It does not contain blood vessels, lymphatics, or nerves and is
composed of a dense extracellular matrix (ECM) and a sparse distribution of specialized
cells called chondrocytes.33 Chondrocytes are responsible for synthesizing articular
cartilage during development, maintaining normal adult cartilage, and the degeneration of
cartilage during KOA.34 Proteoglycans, a type of protein, are embedded within the
collagen matrix of the cartilage and draw water into the cartilage.10 The high water
content of the cartilage provides resistance to compressive forces within the joint. In
addition to collagen fibre structure and ECM, chondrocytes contribute to the organization
of four zones within articular cartilage: the superficial zone, the middle zone, the deep
zone, and a calcified cartilage zone. The calcified cartilage is vital in securing the
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articular cartilage to the bone by anchoring the deep zone’s collagen fibrils to the
subchondral bone.33 A sharp boundary referred to as the tidemark separates the noncalcified and calcified cartilage zones.35 In OA, the tidemark commonly becomes
replicated, which is taken as an indicator of the underlying osteoarthritic process with the
calcification front advancing into the non-calcified cartilage of the deep zone.36,37

1.1.3

Clinical presentation and symptoms

OA can only be clinically diagnosed if patients present with symptoms, and preventing or
alleviating these symptoms is the goal of the intervention.10 The most common OA
symptom is joint pain, which tends to worsen with activity, especially following a rest
period.38 KOA patients frequently complain of joint instability leading to buckling,
especially when descending stairs or steps.39 Physician examinations of KOA patients are
coupled with medical imaging to determine disease presence and severity.10
Traditionally, weight-bearing radiography has been used to diagnose KOA through
measuring tibiofemoral (TF) joint space narrowing (JSN), which serves as an indirect
measure of femoral articular cartilage (FAC) loss. Medical imaging is rarely required to
confirm the diagnosis of KOA; however, imaging is helpful to evaluate the severity of
joint damage and to monitor disease progression longitudinally.40 Semi-quantitative
scoring systems, such as the Kellgren-Lawrence (KL) grading scale and the Osteoarthritis
Research Society International (OARSI) atlas grading system, define the presence of
KOA using TF JSN, where decreases in FAC quality and quantity are interpreted as
increased KOA severity.41,42 The KL grading scale defines OA severity in five grades (04, normal to severe) using a combination of osteophyte and JSN severity. The OARSI
atlas uses separate scoring for osteophytes and JSN (grading 0-3). Using the KL system, a
grade ≥ 2 is the typical threshold for OA, while the OARSI atlas threshold consists of
three separate criteria: either JSN grade ≥ 2, osteophyte grade ≥ 2, or grade 1 JSN in
combination with grade 1 osteophyte.43,44

1.1.4

Progression and treatment

In OA, the articular cartilage matrix undergoes proteolytic degradation, which is
associated with increased synthesis of the same or slightly altered matrix components by
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the chondrocytes.45 This results in early morphological changes in the cartilage and later
losses in cartilage volume. Osteophyte development and significant vascularity changes
within bone might play an essential role in the pathogenesis of OA, but these events are
less understood. Furthermore, signalling molecules released from the cartilage,
synovium, and bone all have an impact on chondrocyte function. Although OA was
previously thought of as non-inflammatory arthritis, improved detection methods
demonstrate that inflammatory pathways are upregulated in OA.46
While there is no cure for OA, several treatment avenues and methods focus on
alleviating symptoms with varying efficacies. The European League Against Rheumatism
and

OARSI

have

previously

published

evidence-based

OA

treatment

guidelines.47,48,49,50,51 The American College of Rheumatology has published the most
recent guidelines for managing hand, hip, and knee OA.52 One treatment option for KOA
is regular physical exercise. Regular physical activity in KOA patients effectively reduces
pain and improves function.53 Improving knee joint stability is vital to prevent worsening
KOA, particularly by increasing strength in the quadriceps and peripheral muscles around
the joint.54 Strength, flexibility, aquatic and aerobic exercises effectively relieve pain and
improve function in patients with lower limb OA.55 For obese patients, weight loss can
reduce the risk of developing symptomatic lower limb OA and improves symptoms once
disease evidence is found.56,57 Studies have also demonstrated that weight loss leads to
structural improvements of cartilage and positive changes in bone and cartilage
biomarkers, especially in KOA.58,59 However, weight reduction is not easy, and patients
with lower limb OA have pain and physical limitations that limit their ability to
participate in physical activity compared to the general population.60,61
Another KOA treatment option is the use of pharmaceutical therapies. Commonly
prescribed medications include paracetamol (also referred to as acetaminophen),
corticosteroids, and nonsteroidal anti-inflammatory drugs (NSAIDs).62 Due to its cost and
safety, paracetamol used to be regarded as the first-line treatment for mild to moderate
OA pain.63 However, systematic reviews and meta-analyses of paracetamol use in KOA
patients suggest low efficacy for pain management.64,65 NSAIDs are an alternative to
paracetamol and are superior for treating widespread pain but can be associated with
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upper gastrointestinal risks and are not recommended for patients with coexisting
cardiovascular conditions.52,63,66,67 Intra-articular treatment options such as glucocorticoid
and hyaluronic acid injections may be recommended when other more conservative
approaches to pain relief have failed. However, intra-articular injections elicit a strong
placebo effect, and new intra-articular treatments may not be appropriate for every
patient.68,69 Ultimately, there is no pharmacological agent that regulatory agencies have
approved as a disease-modifying OA drug.70
In addition to physical activity and pharmacological treatment options, surgical
intervention may alleviate KOA symptoms. Arthroscopy is a minimally invasive surgical
technique where two small incisions are made at the front of the knee to insert surgical
instruments.71 Arthroscopic lavage (irrigation of the joint using a sterile solution) and
debridement (resecting damaged tissue within the knee joint) is focused on removing
loose bodies or other defects in the knee.72 However, the use of arthroscopic lavage and
debridement to treat KOA is controversial as studies have shown no benefit compared to
placebo groups that received only skin incisions.73,74 Other KOA surgical interventions
include high tibial osteotomy, unicompartmental knee replacement, and total knee
arthroplasty (TKA), also referred to as total knee replacement, for end-stage KOA.75
Approximately 80% of patients that undergo TKA procedures are satisfied with their
procedure and experienced improvements in function and pain management, making
TKA an effective treatment option for end-stage KOA.76
Another treatment option for KOA is the use of self-efficacy and self-management
programs, which can be delivered remotely and include education, setting goals,
behavioural interventions, and self-monitoring.77 These programs have shown improved
self-efficacy in patients with KOA in small to moderate effect sizes.78 Furthermore,
mental and social well-being improvements are also effective treatments for some
patients due to the many components of pain, including sleeping problems, loneliness,
and mood disorders.79,80
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1.2
1.2.1

Knee osteoarthritis imaging
X-ray radiography

X-ray radiography is the current gold standard for assessing KOA in clinical and
epidemiological settings. In 1957, Kellgren and Lawrence first described a grading
system known as the KL grading scale, which was adopted as the standard method for
assessing radiographic OA by the World Health Organization in 1961.81 In 1995, an atlas
from OARSI was published and updated in 2007 with better quality images and access to
electronic images.42,82 Radiography is widely available and is associated with lower costs
than MRI. Radiography acquisition times are short, and there is little discomfort to
patients undergoing imaging. The progression and severity of KOA can be monitored
using radiography by assessing cartilage degradation through measurements of JSN and
through observing the presence of osteophytes (Fig. 2).
There are several limitations associated with radiography and radiographic grading scales
for monitoring the progression of KOA. Primarily, radiography lacks soft tissue contrast,
and therefore it cannot be used to visualize the articular cartilage and various other tissues
within the knee. Radiographic measures of JSN operate under the assumption that
decreases in joint space over time represent decreased articular cartilage volume. This
assumption is not entirely valid since the radiographic joint space comprises structures
other than the articular cartilage, such as the meniscus.83,84 Radiographic grading also has
poor sensitivity to detect articular cartilage changes in the early stages of KOA.85 With
radiographic JSN, variations in knee positioning, alignment to the radiographic source,
and joint angulation can decrease reliability and reproducibility.86 Furthermore,
sensitivity to change is limited when using ordinal scales with a small dynamic range
such as 0-4 in the KL grading scale.
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A

B

Figure 1.2 Radiographs of a normal (A) and an osteoarthritic (B) knee. The distance
between the femur and tibia in the medial portion of the osteoarthritic knee is smaller
than the healthy knee due to articular cartilage degradation.

1.2.2

Magnetic resonance imaging

The limitations of radiographic measures of articular cartilage degradation motivated
MRI studies focused on imaging and monitoring KOA. While the risks associated with
radiation exposure in radiography are low, MRI does not expose patients to radiation as
images are created using magnetic fields. MRI has excellent soft-tissue contrast enabling
direct assessments of the articular cartilage. The posterior condylar cartilage, trochlear
cartilage, patellar cartilage, synovium, menisci, and other soft tissues affected by KOA
are more straightforward to visualize using MRI than radiography (Fig. 3). MRI’s high
spatial resolution, excellent soft-tissue contrast, and ability to directly visualize vital
musculoskeletal tissues make it the current clinical standard for KOA imaging. The use
of MRI in clinical KOA studies involves using semi-quantitative scoring methods to
evaluate morphological characteristics of the articular cartilage in combination with those
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of the surrounding tissues to establish symptom risk factors and disease progression.86
The 3D nature of MRI enables assessments of multiple quantitative articular cartilage
measures, including cartilage volume, thickness, surface area, and percentage of bone not
covered by cartilage. MRI-based quantitative measurements can also be used to assess
the efficacy of pharmacologic therapies in KOA and cartilage biochemistry to monitor
early-stage KOA. The MRI Osteoarthritis Knee Score (MOAKS), Boston-Leeds
Osteoarthritis Knee Score (BLOKS), Knee Osteoarthritis Scoring System (KOSS), and
Whole-Organ MRI score (WORMS) are all semi-quantitative scales that utilize
MRI.87,88,89,90

Figure 1.3 MRI scan of a healthy knee with arrows highlighting the articular cartilage.
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Measurements of articular cartilage thickness using MRI have been investigated as a
quantitative alternative to radiographic JSN measures to determine KOA severity and
progression.91 However, articular cartilage thickness measurements are associated with
limitations for KOA assessments. The thickness of articular cartilage in the knee joint
varies diurnally, while the cartilage volume does not, leading to variability in thickness
measurements.92 Additionally, longitudinal assessments of cartilage thickness changes
are limited by reselecting the identical section of cartilage for measurements in future
sessions.93 An alternative to cartilage thickness measurements for assessing degradation
is cartilage volume. Measurements of articular cartilage volume enable the entire
cartilage structure to be assessed instead of a single anatomical slice with thickness
measurements.
Although MRI has excellent soft-tissue contrast for monitoring the progression and
severity of KOA, it is associated with several limitations. MRI is not feasible for pointof-care (POC) disease monitoring due to the limited mobility and physical size of MRI
systems. Patients diagnosed with KOA may have substantial mobility limitations and
severe pain when moving from one location to another. Another limitation of MRI is its
high manufacturing and operating costs. Installing an MRI scanner requires constructing
a specialized MRI scanning facility which increases costs and may not be possible in all
locations where MRI would be needed. The limited number of MRI scanners available
for clinical use in Canada results in patients being placed on long waitlists before
receiving the imaging necessary for their care. Additionally, the time it takes to acquire
an MRI scan can be long, requiring patients to remain motionless throughout the entire
acquisition process. The long scan time is not ideal for patients that experience pain when
remaining motionless in the positions required for MRI acquisitions. An ideal imaging
modality for monitoring the progression and response to treatment of KOA would be
capable of bedside image acquisition, be widely available, have low operating and
manufacturing costs, and have relatively short acquisition times.

1.2.3

Conventional ultrasound

Conventional two-dimensional (2D) US imaging is a high-resolution, widely accessible,
and relatively low-cost modality that creates images using acoustic waves transmitted and
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received by a transducer. Conventional 2D US is capable of real-time imaging, meaning
that 2D US images are continually acquired as the transducer is manipulated on the
patient’s skin. The real-time imaging capability enables the operator to rapidly interrogate
an entire region-of-interest (ROI). Additionally, real-time imaging enables images of the
patient to be acquired during flexion or extension of their joints to assess how joint
tissues respond to the motion. The handheld nature of 2D US enables the operator to
manipulate the transducer in any orientation to acquire images that would be difficult or
impossible to acquire with radiography. The portability of US machines also enables
images to be acquired directly at the patient’s bedside, increasing accessibility to patients
without increasing patient discomfort. 2D US imaging has been increasingly used to
assess rheumatological and musculoskeletal diseases. Previous studies have demonstrated
that US can be used to detect early inflammatory soft tissue and erosive bone lesions with
correlations to MRI, one of the current clinical standards for monitoring arthritis.94,95,96,97
The Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) US group
has developed a semi-quantitative grading scale to implement 2D US into KOA research;
however, this scale has not been formally validated.98 Due to its high water content, FAC
appears hypoechoic or darker and is easy to visualize using 2D US to monitor the
progression of KOA (Fig. 4a). The suprapatellar synovial membrane is also visible using
2D US, enabling assessments of synovitis in KOA patients (Fig. 4b).
There are several limitations associated with conventional 2D US imaging. Since 2D US
is a 2D imaging modality, it is difficult to interpret the 3D anatomy. Operators must
cognitively integrate multiple 2D images to reconstruct the necessary 3D anatomy, which
is inefficient and can lead to variability. 2D US techniques can estimate tissue volumes
from measurements of height, width, and length in two orthogonal views by assuming
idealized geometries. However, 2D US tissue volume measurements are associated with
low accuracy, high variability, and high operator dependency during image acquisition.
Additionally, human tissues are not always easily represented by idealized geometries,
which is especially the case for the FAC and suprapatellar synovium in the knee, leading
to incorrect volume estimations. With 2D US, it is impossible to acquire viewing planes
perpendicular to the length of the transducer without rotating the transducer and changing
the conventional viewing plane. This limitation is apparent during OA diagnosis and
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monitoring, which may require an arbitrary selection of viewing planes for assessments
and measurements.99

A

Soft tissues

Cartilage

Femur

B

Patella

Soft tissues

Femur
Figure 1.4 2D US images of the trochlear FAC (A) and suprapatellar synovial bursa (B)
of a healthy knee. Images were acquired with an Aplio i800 US machine (Canon Medical
Systems Corporation, Ōtawara, Tochigi, Japan) equipped with a 14L5 linear transducer
(frequency range 3.8 MHz - 10.0 MHz).
Another limitation of conventional 2D US imaging is that the field-of-view (FOV) is
small compared to radiography and MRI. The lateral dimension of a conventional 2D US
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image acquired using a linear transducer is determined by the length of the transducer
itself. The axial dimension of a conventional 2D US image is the depth at which the
image is acquired. Higher frequency 2D US transducers result in increased spatial
resolution but decreased penetration depth. In general, conventional 2D US cannot image
deep tissues at high spatial resolutions. It is difficult to interrogate entire tissues of
interest with a single 2D US image due to the limited FOV. Multiple images are often
required, leading to difficulties with interpretation without the surrounding contextual
anatomy. Furthermore, conventional US imaging is not well-suited to image bony or airfilled anatomy, making it challenging to acquire 2D US images of the knee joint due to
the presence of the patella, femur, and tibia.

1.3

3D ultrasound imaging

The limitations of conventional 2D US imaging can be overcome using 3D US imaging.
3D US operates on the same physical principles as conventional 2D US imaging, where
images are created by transmitting and receiving acoustic waves. 3D US imaging
provides the operator with an interactive 3D representation of the anatomy eliminating
the need for mentally reconstructing several 2D US images simultaneously. Three main
factors must be optimized during the acquisition of 3D US images:
1. The scanning must be sufficiently rapid to avoid image artifacts due to
involuntary operator and patient motion.
2. The location and orientation of the 2D images must be accurately known to avoid
geometric distortions in the reconstruction of the 3D image.
3. The scanning device must be simple and easy to operate to avoid complicated
scanning procedures.99
Several methods for acquiring 3D US images have been developed that satisfy these
optimization factors. One approach uses a 2D array of transducer elements, also referred
to as a matrix array, which enables acquisition in two simultaneous imaging planes.
However, many elements and wiring requirements lead to high manufacturing costs.100
Another method of acquiring 3D US images is for the operator to manipulate a 2D
transducer manually. The trajectory of the transducer is then measured by tracking its
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position and orientation during acquisition.101,102 The position and orientation of the
transducer can be tracked in real-time using an external optical tracking system that uses
infrared cameras to track passive marker spheres that can be mounted to the transducer. A
minimum of three spheres in a non-linear orientation is needed to track all degrees of
freedom during transducer manipulation. An additional approach is to translate a
conventional 2D US transducer along a path using a motorized drive mechanism with a
known trajectory.103 With this approach, 3D US images are formed by continually
acquiring consecutive 2D US images as the transducer is translated along the subject to
sweep out a 3D geometry. Consecutive 2D US images are then reconstructed to form a
3D volume using automated software.99 This thesis focuses on applying mechanical 3D
US imaging to monitoring KOA.
With mechanical 3D US image acquisition, there are different trajectories that the
transducer can follow to produce unique 3D image geometries. Tilt scanning enables the
transducer to be tilted around a contact point with the patient to sweep out a fan
geometry. With tilt scanning, 2D US images are acquired at regular angular intervals with
images radial to the rotation axis. However, the fan geometry of tilt scanning is
associated with limitations. The varying distances between consecutive 2D US images as
depth increases result in an anisotropic spatial resolution for the resulting 3D image.
Additionally, US beam spreading in the elevational direction and within the 2D US
acquisition plane leads to degradation of the spatial resolution with increasing depth. 104
Alternatively, a linear scanning device translates the transducer linearly along the
patient’s skin. With linear scanning, 2D US images are acquired at regular spatial
intervals to sweep out a rectangular geometry. The rectangular geometry of linear
scanning provides a broader FOV at shallow depths but a smaller FOV at increased
depths than tilt scanning. Therefore, linear scanning would be better suited for monitoring
KOA progression due to the superficial knee anatomy.
3D US images are comprised of multiple imaging planes. The imaging plane that is
parallel to the direction of conventional 2D US is referred to as the acquisition plane,
while the perpendicular plane is referred to as the reconstruction plane (Fig. 5). The
acquisition plane possesses the exact spatial resolution as the 2D US transducer used to
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acquire the images. In contrast, the reconstruction plane has a spatial resolution equal to
the elevational resolution of the transducer. The different spatial resolutions of these two
imaging planes result in an anisotropic spatial resolution for the overall 3D US image.
The translation speed of the 2D US transducer on the 3D US scanner can be varied to
match the sampling rate to the frame rate of the US machine. The translation distance and
speed of the US transducer also affect the 3D US acquisition time. Typically, 3D US
images can be acquired in approximately 10 seconds or less.

Figure 1.5 3D US image of the trochlear FAC from a healthy knee with labelled
acquisition and reconstruction planes.
With mechanical 3D US acquisition, the drive mechanism’s housing can be designed to
allow for easy, ergonomic handheld positioning and manipulation. Because of the
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flexibility in design, the transducer mounting attachment can be designed to conform to
any transducer, making 3D US compatible with any US machine. Additionally, since 3D
US acquisition forms images using consecutive 2D US images, it can be implemented in
any application where 2D US is used. 3D US imaging also reduces variability and user
dependency when measuring tissue volumes and provides the ability to select any
arbitrary imaging plane for disease diagnosis and monitoring.

1.4
1.4.1

Medical image processing and analysis
Segmentation

Image segmentation, also referred to as labelling or contouring, is the process of
identifying image pixels or defining boundaries for all pixels within a given group or
region that share a common property or belong to the same tissue type or organ.105
Segmenting anatomical structures from medical images provides a unique visualization
of the tissues of interest without the surrounding anatomical information. The goldstandard method for image segmentation is manual segmentation, which is completed
manually by tracing regions within an image that belong to the tissue of interest.
Becoming proficient in manual image segmentation requires training and practice and the
necessary anatomical and medical imaging background knowledge for a given
application.106 Segmentations of FAC are necessary to acquire thickness, surface area,
and volume measurements. The quality of the segmentation also directly impacts the
accuracy of the measurements.107,108 However, manually segmenting images is subjective
as the individuals performing the task make their own decisions based on prior
knowledge and experience, leading to inconsistencies.109,110

1.4.2

Registration

In medical imaging, registration is a processing technique that is used to align two or
more images or segmentations of the same scene taken at different times, viewpoints, or
with different modalities.111 Image or segmentation registration is used to compare or
combine valuable information in multiple images or segmentations. Applications of
registration in the medical imaging field include the fusion of anatomical and functional
images acquired from different modalities to obtain more information about the tissue of
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interest.112 Registration involves designating one image or segmentation as the reference
and applying a geometric transformation to the other image or segmentation to align it
with the reference.113 Comparing segmentation-based measurements of KOA
progression, such as FAC volume, provides the ability to assess the performance of new
methods for acquiring these measurements.

1.5
1.5.1

Challenges in imaging-based knee arthritis monitoring
Previous work and unmet need

Developing new imaging modalities, or repurposing existing technologies for novel
applications, requires rigorous testing and validation before implementation into standard
clinical care. When working with new applications, it is crucial to evaluate the workflow
for feasibility in a clinical setting and validate the system’s measurement capabilities and
accuracy. We have previously validated the measurement errors of our tilt and linear 3D
US scanning devices with tungsten filament phantoms and volumetric agar phantoms.
The linear scanner demonstrated the ability to acquire Euclidean distance and volumetric
measurements with errors < 2% compared to the known phantom dimensions.114
However, measurements made from US images can be subject to intra- and inter-rater
variabilities, and idealized phantom images may not represent complex human anatomy.
Therefore, a study with human volunteers that possess healthy knees is needed to test the
intra- and inter-rater reliabilities of using our 3D US device to measure the volume of
FAC and develop an efficient clinical workflow.

1.5.2

Hypothesis

The central hypothesis of this thesis is that 3D US imaging can be used to quantify the
volume of FAC with similar reliability and accuracy to the current clinical standard of
MRI.

1.5.3

Objectives

The objectives of this thesis are to:
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1. Assess the intra- and inter-rater reliabilities of manual FAC segmentations of
healthy knees from MRI and 3D US.
2. Assess the validity of segmentation-based FAC volume measurements using 3D
US compared to the current clinical standard of MRI in healthy knees.
In this context, validity refers to the degree of similarity between manual segmentationbased FAC volume measurements acquired using 3D US imaging in comparison to FAC
volume measurements acquired using MRI in healthy volunteers.

1.6

Thesis outline

This thesis will address the specific objectives in one manuscript (Chapter 2).
Chapter 2: Reliability and concurrent validity of three-dimensional ultrasound for
quantifying knee cartilage volume
Chapter 2 describes our work on developing and validating a handheld mechanical 3D
US acquisition device that will be used to monitor the progression of KOA. The ability to
monitor the progression of KOA at the patient’s bedside will improve clinical workflow
by enabling clinicians and researchers to obtain more information without added
complexity or additional stress and discomfort to patients. This device will be beneficial
in longitudinal and interventional studies to detect FAC volume changes over time.
Our handheld mechanical 3D US device demonstrated excellent intra- and inter-rater
reliabilities and strong concurrent validity with MRI when acquiring FAC volume
measurements from healthy knees. 3D US imaging can decrease the overall costs of KOA
monitoring and significantly improve the feasibility of FAC volume measurements
during KOA clinical trials and patient care.
Chapter 3: Conclusions and future work
This chapter provides an overall conclusion of the previous chapter and will discuss
future work to address the unmet needs from this thesis.
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Chapter 2
2

Reliability and concurrent validity of three-dimensional
ultrasound for quantifying knee cartilage volume

Handheld 3D US imaging has the potential to improve clinical workflow and decrease
the overall costs of KOA imaging and monitoring at the patient’s bedside. The purpose of
Chapter 2 is to present the validation of a handheld mechanical 3D US acquisition device
for measuring the volume of FAC compared to MRI.
The contents of this chapter have previously been published in Osteoarthritis and
Cartilage Open: Papernick S, Dima R, Gillies DJ, Appleton CT, Fenster A.
Osteoarthritis and Cartilage Open. 2020;2(4). The author retains the right to reuse this
article in this thesis – Appendix B.

2.1

Introduction

KOA is a whole-joint disease with a prevalence of 7-17% among adults 45+ years old
and is increasing with rising obesity rates and population ageing.1,2 KOA affects all knee
joint tissues, leading to cartilage degradation, subchondral bone remodelling, and muscle
atrophy.3 Cartilage degradation, a hallmark of KOA, has motivated efforts to characterize
disease severity through measures of FAC loss, where decreases in FAC quality and
quantity are interpreted as increased KOA severity. Semi-quantitative scoring systems,
such as the KL grading scale, define the presence of KOA using TF JSN as a surrogate
for FAC loss. Most imaging-based KOA scales target TF cartilage because of easy
visualization with weight-bearing radiography. Although radiographic JSN may represent
FAC loss, radiographic grading has poor sensitivity to detect FAC changes in early-stage
KOA.4 Furthermore, radiographic JSN suffers from limited reproducibility for visualizing
3D features due to variations in knee joint angulation.5 Additionally, JSN is a composite
of meniscal positioning and degeneration, which are not necessarily associated with KOA
severity.6,7
Limitations of radiographic JSN have motivated MRI investigations of FAC as a
discriminative and evaluative KOA tool. The MOAKS, BLOKS, KOSS, and WORMS
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are all MRI-based semi-quantitative scales that have shown excellent reliabilities in OA
populations.8,9,10,11 Furthermore, compositional MRI techniques produce quantitative
measurements of cartilage biochemistry and have primarily been developed to investigate
early-stage KOA. Due to the ability of MRI to assess the status of whole joint cartilage
with reasonable spatial resolution, it has been largely accepted as the gold standard for
KOA FAC assessments. While MRI has accelerated the scientific and medical
communities’ understanding of KOA, it has limitations. MRI is not feasible for POC
disease classification due to high manufacturing and operating costs, long acquisition
times, and inaccessibility to all patients at all times.12 However, while other modalities
may be less expensive and more accessible than MRI, finding individuals that possess the
expertise needed to interpret images in under-served areas of the world is challenging.
Conventional 2D US is widely accessible, relatively inexpensive, and overcomes the
limitations associated with MRI. 2D US is a high-resolution imaging modality that has
been increasingly used for POC assessments of rheumatological diseases.13,14,15,16 2D US
has been implemented in KOA research via OMERACT US working group’s semiquantitative grading scale.17 However, this scale has not been formally validated, and
conventional 2D US is associated with limitations. Clinicians must cognitively integrate
multiple 2D images to mentally reconstruct 3D anatomy, which is inefficient and leads to
operator variability.18 Additionally, 2D US tissue volume calculations require
measurements of height, width, and length in two orthogonal views and are associated
with low accuracy, high variability, and large operator dependency. Furthermore,
sensitivity to change is limited when using ordinal scales with a small dynamic range
such as 0-3 in the OMERACT scale. Alternatively, 3D US techniques involve translating
a 2D US transducer while continually acquiring images that are reconstructed into a 3D
image. 3D US imaging overcomes the limitations of 2D US and may fill the clinical need
for an objective imaging-based POC tool for assessing KOA status, progression, and
response to treatment.
3D US techniques have been applied to neonatal, gynecological, and vascular
applications, among others.19,20,21 We have developed a handheld mechanical 3D US
device to provide POC assessments of trochlear FAC (tFAC). The objectives of this
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cross-sectional study were to investigate the intra- and inter-rater reliabilities of our 3D
US scanner for measuring tFAC volumes in healthy volunteers and assess its concurrent
validity compared to the current clinical standard of MRI. We hypothesized that tFAC
volumes measured from 3D US would demonstrate excellent reliability (ICC > 0.90) and
be strongly correlated (ρ > 0.80) to MRI measurements in the same ROI.

2.2

Methods

Twenty-five volunteers over the age of 18 without a recent history of chronic knee joint
pathology (healthy knees) in the year prior to the study were recruited for MR and 3D US
knee imaging. The imaging protocol was approved by the Research Ethics Board at
Western University Canada, and all volunteers provided written informed consent prior to
imaging (Appendix A). Knees were deemed healthy if volunteers denied experiencing
knee pain on most days of the weeks prior to this study and had not been diagnosed with
any type of knee arthritis. Volunteers with prior knee injuries and/or surgeries that
occurred before the year leading up to the study were not excluded from the cohort if they
denied experiencing frequent knee symptoms including pain, aching, or stiffness on most
days of the weeks prior to this study.

2.2.1

Image acquisition

MRI scans were acquired on a 3.0 Tesla MR system (General Electric Healthcare,
Milwaukee, WI, USA) using a 3D Multiple Echo Recombined Gradient Echo (MERGE)
sequence in accordance with the OARSI recommendations for KOA imaging clinical
trials.22 The MERGE sequence is a T2*-weighted pulse sequence for musculoskeletal
imaging that enables direct visualization of FAC. An HD T/R Knee Array Coil (8
Channels) was used while volunteers were positioned supine with minimal knee flexion.
Images were acquired in the sagittal plane with voxel sizes of 0.63 x 0.63 x 0.40 mm3, an
average of 250 slices, a reconstructed matrix size of 256 by 256 voxels, and an FOV of
16 cm. The excitation flip angle was 5° with a repetition time (TR) of 30 ms and an echo
time (TE) of 11.71 ms. The MERGE sequence scan time for one knee was 4 minutes and
27 seconds. Total scan time was 45 minutes including both knees.
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3D US images were acquired using an Aplio i800 US machine (Canon Medical Systems
Corporation, Ōtawara, Tochigi, Japan) equipped with a 14L5 linear transducer with a 58
mm footprint length and an operating frequency of 10 MHz (3.8 MHz – 10.0 MHz). The
2D US transducer was mounted to our 3D US scanner using a custom 3D-printed mould
(Fig. 1). Our 3D US device consisted of a motorized drive mechanism that linearly
translated the transducer over 4.0 cm along the patient’s skin. 2D US images were
continually acquired at regular spatial intervals which were reconstructed into a 3D image
immediately after scanning via computer software.18 Our 3D US scanner has previously
been validated on tungsten filament phantoms and volumetric agar phantoms,
demonstrating the ability to acquire Euclidean distance and volumetric measurements
with errors < 2%.23 For 3D US acquisition, volunteers were positioned supine and
instructed to flex their knee to the maximum range of motion without eliciting pain. 3D
US images of the tFAC were acquired at the distal end of the femur, proximal to the
patella during maximum knee flexion (Fig. 2). 120 2D US images were acquired in the
transverse plane with transducer translation along the perpendicular axis. Reconstructed
3D US image voxel sizes were 0.058 x 0.058 x 0.33 mm3 with 2D US in-plane image
dimensions of 968 x 694 voxels. 3D US acquisition time was 15 seconds for one knee.
The time period between MRI and 3D US imaging sessions was as short as possible
while still accommodating to the individual schedules of the participating volunteers.
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Figure 2.1 (A) Schematic diagram of our handheld mechanical 3D US acquisition
device. The conventional US transducer (gray) is mounted to a motorized drive
mechanism (green) via a custom 3D-printed transducer mould (purple). Pressing the
button located on the top of the device initiates a 3D US acquisition. (B) Image of the 3D
US acquisition device in the hand of a user.

Figure 2.2 Image depicting the knee in full flexion during 3D US image acquisition.
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2.2.2

Manual segmentation

MRI voxel resampling was performed to ensure that the segmentation pixel spacings
were substantially smaller than the smallest FAC image feature. Voxel resampling was
conducted in MATLAB R2019b (MathWorks, Natick, Massachusetts, USA) using the
interp2 function with the spline interpolation method. The resampled voxel size was 0.15
x 0.15 x 0.40 mm3 to provide a balance between segmentation sensitivity and
computation time.
Manual tFAC segmentations were completed by two raters (SP, RD) on MRI and 3D US
after receiving training during three formal calibration sessions with a rheumatologist
possessing advanced diagnostic and interventional musculoskeletal ultrasonography
training (CTA). One rater had no prior experience with medical image segmentation but
possesses a medical physics academic background with courses in medical imaging
modalities including US and MRI. The other rater is a registered diagnostic medical
sonographer with formal training and clinical experience in medical imaging.
Segmentations were performed in the open-source software 3D Slicer (3D Slicer 4.11.0
Preview Release) using the segment editor module and were conducted in the sagittal
MRI and transverse 3D US planes.24 Segmentations of both MRI and 3D US were
completed using every second 2D image to decrease segmentation time for both
modalities without a reduction in sensitivity to tFAC volume changes.25 Segmented 2D
images were interpolated using a morphological contour interpolation algorithm in 3D
Slicer, resulting in an average of 146 and 92 segmented 2D images per MRI and 3D US
image, respectively.26 Both raters were blinded to the other imaging modality during
segmentations such that MRI segmentations were completed without the help of 3D US
image and vice versa. Each rater completed segmentations in a random order on each
modality.
During MRI segmentations, the posterior condylar cartilage was excluded by defining the
anterior border of the posterior aspect of the lateral and medial menisci as a segmentation
border to further reduce segmentation times (Fig. 3a, b). The hyperintense synovial
membrane lining Hoffa’s fat pad was excluded from MRI segmentations. For 3D US
segmentations, the anterior hyperechoic tFAC surface and the hyperechoic border of the
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cortex were defined as boundaries for the anechoic cartilage (Fig. 3c, d). With these
boundaries and definitions, total segmentation times were approximately 45 to 60
minutes per knee for MRI and 20 to 30 minutes per knee for 3D US. Five knees from
separate volunteers were randomly selected by each rater and re-segmented on MRI and
3D US. Repeated segmentations were conducted during sessions separated by a twoweek “washout” period to reduce the probability of each rater relying on memory when
conducting a repeated segmentation.

Figure 2.3 MERGE MRI (A) and 3D US (C) images of the trochlear articular knee
cartilage outlined by the white arrows in the sagittal MRI and transverse US planes of a
healthy volunteer, accompanied by the same images with an overlaid MRI (B) and 3D
US (D) slice that has been manually segmented.
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2.2.3

Reliability and validation analysis

MRI and 3D US segmentations were registered via manual initialization followed by
automated surface-based registration in 3D Slicer (Fig. 4). Initialization involved
manipulating 3D US tFAC models using linear transformations and rotations along the
three Cartesian axes to align the segmentations with MRI using the intercondylar notch as
an anatomical landmark. An automatic surface-based registration method (Jean-Baptiste
& Vinicius Boen, University of Michigan) was applied to the segmentations to complete
the registration. Intra- and inter-rater reliabilities were assessed using the same
registration procedures. Reliability analysis was conducted using the entire segmented
area of MRI and 3D US tFAC models, while validation between modalities involved
additional trimming of MRI segmentations. MR images captured a larger FAC FOV than
3D US, resulting in segmentations that did not represent identical anatomical ROI when
comparing modalities. Therefore, MRI segmentations were manually trimmed using the
overlaid 3D US segmentations as guides, ensuring that tFAC models represented the
same ROI on both modalities. Registration and trimming were repeated on five knees
selected at random during sessions separated by a two-week “washout” period.
Segmentation volumes were computed by 3D Slicer, and the percent differences between
MRI and 3D US volumes were calculated. The mean surface distance (MSD), Hausdorff
distance (HD), and Dice similarity coefficient (DSC) were computed as these metrics are
widely used to compare and evaluate segmentations.27 MSD represents the mean distance
from a point on one surface to the nearest corresponding point on the other surface, while
HD is the largest distance from a point on one surface to the closest point on the other
surface (Fig 4e). DSC provides a measure of similarity in terms of overlap between
segmentations and ranges from 0% (no overlap) to 100% (identical objects). MSD and
HD

values

were

computed

using

the

open-source

software

CloudCompare

(CloudCompare v2.11 beta), and DSC values were computed using the segment
comparison module in 3D Slicer (Csaba Pinter, PerkLab, Queen’s University, Canada).

39

Figure 2.4 Manual segmentations of the FAC from MRI (A) and 3D US (B) images. 3D
US segmentations were registered to MRI using a semi-automated surface-based
registration algorithm (C). MRI segmentations were then trimmed (D) to ensure both
MRI and 3D US segmentations covered the same cartilage region for comparison
purposes. (E) Colour map representing the absolute distance (mm) between a given MRI
and 3D US segmentation pair from the same knee of a volunteer. The distance map has
been overlaid on the 3D US segmentation and represents the distance from each point to
the nearest points on the MRI segmentation.
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2.2.4

Statistical analysis

Statistical analyses were performed using SPSS (SPSS Statistics v26; IBM, Armonk, NJ).
All data were initially tested for normality using the Shapiro-Wilk test. Intra- and interrater segmentation reliabilities from MRI and 3D US for both raters were assessed using
intraclass correlation coefficients (ICCs). Intra-rater ICCs were based on a single-rating,
absolute-agreement, 2-way mixed-effects model, while inter-rater ICCs were based on a
single-rating, absolute-agreement, 2-way random-effects model. ICCs were interpreted as
less than 0.50 indicating poor reliability, between 0.50 and 0.75 indicating moderate
reliability, between 0.75 and 0.90 indicating good reliability, and greater than 0.90
indicating excellent reliability.28 Bland-Altman plots were used to assess differences
between intra- and inter-rater tFAC volumes along with differences between MRI and 3D
US segmentations. A cumulative percentile plot was used to observe the relationship of
the differences between MRI and 3D US tFAC volumes. Correlations between tFAC
volumes calculated as the mean of the two raters from MRI and 3D US segmentations
were determined using Spearman Rank-Order Correlation due to the non-normal
distribution of data. Linear regression analysis was conducted using MRI segmentation
volumes as predictors for 3D US tFAC volumes and the enter method for equation
construction.

2.3

Results

The demographic data of the volunteers are shown in Table 1 and was available from 24
of the 25 participants.
Table 2.1 Demographic data of twenty-four out of the twenty-five volunteers.
Volunteers with healthy knees
% Women

58.3

Age [year] (mean ± SD)

29.9 ± 14.5

Height [m] (mean ± SD)

1.68 ± 0.11

Weight [kg] (mean ± SD)

67.0 ± 14.8

BMI [kg/m2] (mean ± SD)

23.4 ± 3.3
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2.3.1

Reliability

Similar mean segmentation volumes and mean absolute volume differences between
intra- and inter-rater comparisons were observed using the same modality for each rater
(Table 2, Fig. 5). The smallest ICC was 0.83 (0.48, 0.94) and was observed for the interrater comparison of MRI, while the largest ICC was 1.00 (0.98, 1.00) and was observed
for the intra-rater 3D US comparison for rater 1 (Table 3). Global mean MSD and HD
were smaller for 3D US than MRI for intra- and inter-rater comparisons, while DSC was
larger for 3D US than MRI during all comparisons (Table 3).
Table 2.2 Mean volumes ± standard deviations (SDs) for all intra-rater and inter-rater
comparisons, along with the absolute volume difference ± SD between MRI and 3D US.
The mean volumes and absolute differences for repeated registrations and trimmings of
MRI segmentations are also provided.
Mean Volume
[cm3]

Mean Volume
(repeated) [cm3]

Absolute Difference
[cm3]

MRI (rater 1)

4.71 ± 1.18

4.76 ± 1.20

0.232 ± 0.152

MRI (rater 2)

4.56 ± 1.10

4.20 ± 1.04

0.366 ± 0.351

3D US (rater 1)

2.52 ± 1.01

2.53 ± 0.96

0.0516 ± 0.0531

3D US (rater 2)

2.15 ± 0.92

2.17 ± 1.08

0.167 ± 0.111

MRI

4.79 ± 1.23

4.38 ± 1.03

0.494 ± 0.465

3D US

2.29 ± 0.72

2.30 ± 0.64

0.155 ± 0.134

2.13 ± 0.54

0.0173 ± 0.0166

Intra-rater (n = 5)

Inter-rater (n = 25)

Registration & trimming (n = 5)
Single rater

2.14 ± 0.56
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Figure 2.5 Bland-Altman plots assessing intra-rater test/re-test reliability of rater 1 with
MRI (A) and 3D US (B), and rater 2 with MRI (C) and 3D US (D). Bland-Altman plots
assessing inter-rater reliability between the two raters using MRI (E) and 3D US (F) to
complete segmentations. Mean differences in segmentation volumes are indicated by a
solid line and mean ±1.96 SD are indicated by dashed lines.
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Table 2.3 Intra- and inter-rater reliability ICCs with 95% confidence intervals (CIs) for
manual MRI and 3D US segmentations, along with repeated MRI and 3D US
registrations and trimmings. The MSD, HD, and DSC values ± SD for all comparisons
are also presented.
ICC (95% CI)

P value

MSD [mm]

HD [mm]

0.218 ±
0.109
0.499 ±
0.275
0.126 ±
0.024
0.256 ±
0.143

2.88 ±
1.37
6.66 ±
2.76
1.76 ±
0.35
3.70 ±
2.23

0.274 ±
0.122
0.243 ±
0.133

3.51 ±
1.77
2.89 ±
1.72

0.101 ±
0.090

1.72 ±
0.94

DSC [%]

Intra-rater (n = 5)
MRI (rater 1)
MRI (rater 2)
3D US (rater 1)
3D US (rater 2)

0.97 (0.79,
1.00)
0.90 (0.25,
0.99)
1.00 (0.98,
1.00)
0.98 (0.84,
1.00)

0.001
0.002
< 0.0001
0.0003

87.3 ± 2.8
83.5 ± 4.6
92.9 ± 0.2
88.1 ± 2.6

Inter-rater (n = 25)
0.83 (0.48,
0.94)
0.96 (0.90,
0.98)

MRI
3D US

< 0.0001
< 0.0001

83.1 ± 3.6
86.4 ± 3.1

Registration & trimming (n = 5)
Single rater

2.3.2

1.00 (0.99,
1.00)

< 0.0001

94.3 ± 4.4

3D US to MRI registration and trimming

The mean percent difference between MRI and 3D US volumes averaged across all
comparisons including both raters individually, following registration and trimming, was
16.7 ± 12.9 % (n = 50). 3D US tFAC volume measurements were larger than MRI
volume measurements in 88% of the comparisons between the two modalities (Fig. 6a,
b). Spearman Rank-Order Correlation revealed a strong correlation between MRI and 3D
US volumes (ρ = 0.884 (0.746, 0.949), p < 0.0001), and linear regression resulted in R2 =
0.848 (0.750, 0.950), p < 0.0001, and Y = 1.29 * X – 230 (Fig. 6c). Global mean MSD,
HD, and DSC between registered segmentations averaged between both raters were 0.375
± 0.071 mm, 2.85 ± 1.18 mm, and 71.2 ± 6.5 %, respectively (n = 25).
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Figure 2.6 (A) Bland-Altman plot assessing the relationship between MRI and 3D US
segmentation volumes as the mean for both raters. Mean differences in segmentation
volumes are indicated by a solid line and the mean ±1.96 SD are indicated by dashed
lines. (B) Cumulative percentile plot depicting the volume difference between MRI and
3D US segmentations averaged between both raters. (C) Linear regression plot of MRI
segmentation volumes used as a predictor for 3D US. A line of equality is represented by
the dashed line.

2.4

Discussion

This is the first study investigating the reliability and validation of FAC volume
measurements using 3D US in healthy volunteers. This study focused on validation of
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tFAC volumes, which is important when studying the status and progression of KOA
affecting patellofemoral (PF) articulation. Since KOA affects the entire joint, these
results are pertinent to the study of nearly all KOA phenotypes. Healthy FAC possesses a
relatively smooth and continuous surface without distinct anatomical landmarks that can
be used for registering segmentations, besides the intercondylar notch. Therefore, tFAC
images that included the intercondylar notch enabled registration of MRI and 3D US
segmentations. Additionally, the intercondylar notch can be used as an anatomical
landmark during longitudinal studies to ensure repeated measures are taken from the
same ROI.
3D US imaging is possible in any application involving 2D US since the only
modification required is mounting the 2D US transducer to a 3D US scanning device.
Several studies have previously investigated the application of 2D US for evaluating
femoral condylar cartilage for KOA assessments29,30,31,32. However, quantitative image
analysis of non-invasive knee US has only been reported for cartilage thickness
measurements but not entire cartilage volumes33,34,35. Quantitative image analysis may
provide more sensitive information regarding early KOA than semi-quantitative grading
scales, which are subjective and potentially susceptible to US operator/rater differences.
However, semi-quantitative grading scales are potentially faster than manual quantitative
image analysis. Therefore, this study builds on previous work and is easily implemented
in similar clinical settings.
Many studies have investigated cartilage thickness measurements for assessing KOA
severity36,37. However, thickness measurements are highly variable and dependent on the
FAC ROI being measured, which can vary within subjects due to US transducer
placement and angulation at different time points38,39,40. Detecting changes in cartilage
loss using thickness measurements requires the ability to sample the same ROI with good
test-retest reliability. Volume measurements may overcome these limitations by enabling
quantification of cartilage loss in all dimensions and provide a similar metric to average
cartilage thickness. Furthermore, 3D US may provide meaningful advantages over MRI
for quantifying FAC volume. Our 3D US device is compatible with any commercially
available US machine and is associated with low manufacturing and operating costs.
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Additionally, the portability of our 3D US device enables FAC volume measurements to
be acquired at the patient’s bedside.

2.4.1

Reliability

Intra-rater ICCs for MRI and 3D US demonstrated excellent reliabilities (> 0.90). Interrater ICC for MRI demonstrated good reliability (0.75 – 0.90) while 3D US ICC
demonstrated excellent reliability (> 0.90). Intra- and inter-rater Bland-Altman plots
displayed smaller volume difference variations for 3D US compared to MRI in all
comparisons (Fig. 5). Additionally, global mean MSD and HD were smaller for 3D US
than MRI, and mean DSC for 3D US was higher than MRI for intra- and inter-rater
comparisons (Table 3). Collectively, these results suggest that our 3D US system can
quantify tFAC volume with similar or perhaps superior reliability and precision than
MRI.
The higher spatial resolution of 3D US images acquired with the Canon 14L5 linear
transducer compared to 3.0 Tesla MRI may partially account for reliability and precision
differences. Resolution differences between modalities were most apparent during MRI
segmentations when raters attempted to define the interface between tFAC and the
synovial lining of Hoffa’s fat pad. Differentiating tFAC from slightly hyperintense
synovial lining proved extremely difficult or impossible during MRI segmentations
despite manipulating image contrast. Additionally, the TF cartilage interface was difficult
to identify on MRI as both cartilage structures were equally hyperintense. The synovial
lining of Hoffa’s fat pad along with the TF contact point were not within the ROI of 3D
US acquisitions since images were acquired during maximum knee flexion. Healthy FAC
produced ideal US images with excellent differentiation from surrounding tissues. The
difficulties in identifying borders on MRI likely also contributed to higher segmentation
times compared to 3D US. The MRI and 3D US resolutions were chosen to match what is
routinely used in both patient care and clinical trials for OA to enable comparisons in a
clinically relevant context.
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2.4.2

Validity

3D US tFAC segmentations possessed larger volumes than MRI segmentations.
Considering the higher spatial resolution of US compared to MRI, it is possible that MRI
segmentations were not able to capture the true cartilage volume as effectively as 3D US.
Medial and lateral portions of the tFAC and condylar cartilage become thin and difficult
to delineate from thin adipose tissue and may often not be visible in MRI. Due to the high
spatial resolution of 3D US, the thin medial and lateral portions of tFAC were easily
identified and therefore included in segmentations. This will be of great importance in
clinical studies of joint disease since thinner areas of cartilage are particularly susceptible
to damage and loss in KOA. Our 3D US device was able to visualize tFAC and condylar
cartilage regions that were difficult or impossible to visualize using MRI, providing a
more comprehensive model of the cartilage and improved volume quantifications.
Notwithstanding these differences in absolute cartilage volumes, Spearman Rank-Order
Correlation and linear regression analyses revealed a strong correlation between MRI and
3D US tFAC measurements and that MRI tFAC volumes can predict 3D US volumes.

2.4.3

Limitations and impact

This study was conducted on volunteers with healthy knees rather than KOA patients.
Validating our 3D US system on healthy knees prior to testing with KOA patients was a
necessary first step for developing image acquisition, segmentation, and analysis
protocols. In KOA patients, FAC characteristically develops fissures, abrasions, and other
surface irregularities, whereas healthy cartilage is smooth and continuous. Therefore,
before implementing our 3D US device clinically, the measurement properties of this
system should also be evaluated in KOA patients. Results from a KOA patient study will
enable us to determine if KOA cartilage pathology impacts measurement properties of
our system relative to healthy cartilage. However, given the high resolution and excellent
soft-tissue contrast of clinical US systems, we anticipate our 3D US system will perform
similarly in KOA patients.
Only a portion of FAC was captured in a single pass 3D US acquisition as the FAC
cannot be visualized through the patella and tibia using US. Therefore, knees were
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scanned in maximum flexion proximal to the patella to capture the greatest portion of
FAC possible. However, during maximum knee flexion, the posterior medial and lateral
condylar cartilage are in contact with the tibial cartilage and are not visible with 3D US.
This limitation can be overcome if the tFAC is used as a non-invasive imaging “biopsy”
of knee cartilage, providing clinicians with an indication of FAC status representative of
overall joint health. Additionally, manual trimming of MRI segmentations to match the
3D US ROI was only necessary for validating our system against MRI and would not be
required when using 3D US independently in future studies. While this procedure may
have introduced variability or bias, repeated registrations, along with repeated trimming,
revealed nearly perfect reproducibility (Table 3), indicating that our protocol results in
very little variability or bias.
The weight-bearing condylar cartilage was able to be visualized using our 3D US device.
However, this required additional acquisitions on the medial and lateral sides of the
patella during maximum knee flexion. Since MR images of FAC were acquired during
minimal knee flexion, variations in patella positioning relative to the FAC surface in MRI
compared to 3D US resulted in difficulties registering 3D US condylar cartilage
segmentations to MRI. Therefore, this study focused on the tFAC region for validation
with MRI, but 3D US could be used for monitoring condylar cartilage volume changes
over time without requiring MRI comparisons. Finally, a small subset of patients with
severe KOA may experience limited range of motion, which might interfere with
visualization of the most inferior aspects of the tFAC.
The greatest advantage of our 3D US system is the ability to acquire images quickly,
easily, and comfortably at the patient’s bedside, providing cost-effective and noninvasive assessments of FAC status for reliable longitudinal monitoring. Our 3D US
device could alter the workflow of orthopedic, sports medicine, primary care, and
arthritis clinics by enabling clinicians and researchers to obtain more information without
added complexity or additional stress and discomfort to patients. This technology may be
well-suited to longitudinal and interventional clinical studies where detecting changes in
cartilage volume is required. In the future, this system will also be useful in a routine
clinical care context. Currently, the use of KL grading for assessing KOA progression is
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insensitive to change and relies on indirect features of FAC thinning. MRI-based
measures of cartilage volume are superior to radiographic measures but are limited by
cost, time, accessibility, and patient-related factors, preventing generalized use of
quantitative MRI for KOA. Our study demonstrates that cartilage volume measurements
acquired using 3D US represent a more feasible method to quantitatively assess tFAC
volume with very high reliability and accuracy.
In conclusion, we have demonstrated the reliability and validity of a handheld mechanical
3D US device we developed to quantify tFAC volumes in healthy volunteers. We
demonstrated that 3D US segmentations are associated with excellent intra- and interrater reliabilities and possess strong agreement with MRI tFAC volume measurements.
The tFAC is a vital region of the knee joint for investigating the progression of PF OA
and could also be used as a non-invasive imaging “biopsy” of the FAC to monitor KOA
progression and response to treatment. Future work will assess the reliability of our 3D
US device in KOA patients and the ability to monitor FAC volume changes over time.
Further assessment of measurement properties, including sensitivity to change, is
necessary before its use can be recommended in clinical trials. Future work will also
assess the test-retest reliability of 3D US during image acquisitions separated by time. In
addition to longitudinal construct validity, future work will also assess the intra- and
inter-rater reliability of 3D US cartilage measurements in a longitudinal study to monitor
the progression of tFAC change and degradation for early detection of KOA. 3D US is a
promising, inexpensive, and widely accessible imaging modality for POC assessments of
KOA and will enable clinicians and researchers to obtain additional information without
added complexity or discomfort to patients.
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Chapter 3
3

Conclusion and future directions

This chapter revisits the overarching aims of this thesis and summarizes the findings from
Chapter 2. This chapter also explores the limitations of this work with potential solutions
and discusses directions for future work.

3.1

Overview and research objectives

KOA is one of Canada’s most common chronic health conditions and causes patients to
suffer from debilitating pain, disability, and a decreased quality of life.1,2 X-ray
radiography and MRI are the current clinical standards for diagnosing and monitoring the
progression of KOA and its response to treatment. However, radiographic grading has
poor sensitivity for detecting FAC changes in early KOA and has poor soft-tissue
contrast for visualizing FAC.3 MRI is not feasible for POC KOA assessments due to its
high manufacturing and operating costs, long acquisition times, and inaccessibility to all
patients at all times.4 Conventional 2D US is an alternative, widely accessible, and more
cost-effective imaging modality for monitoring KOA at the patient’s bedside. However,
there are several critical limitations associated with 2D US. Operators must cognitively
reconstruct the necessary 3D anatomy through several 2D images, leading to variability.
Additionally, tissue volume measurements using 2D US are associated with low
accuracy, high variability, and large operator dependency.5 Alternatively, 3D US imaging
techniques involve translating a 2D US transducer while continually acquiring
consecutive images that are reconstructed into a 3D image following an acquisition. 3D
US imaging has the potential to overcome the limitations associated with 2D US and may
fill the clinical need for a POC imaging tool to monitor KOA progression and response to
treatment.
The purpose of this work was to investigate the application of 3D US imaging for
measuring FAC volume without the limitations associated with x-ray radiography and
MRI. The central hypothesis of this thesis was that 3D US imaging could be used to
quantify the volume of FAC with similar reliability and accuracy to the current clinical
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standard of MRI. This thesis sought to test this hypothesis through the following
objectives:
1. Assess the intra- and inter-rater reliabilities of manual FAC segmentations of
healthy knees from MRI and 3D US.
2. Assess the validity of segmentation-based FAC volume measurements using 3D
US compared to the current clinical standard of MRI in healthy knees.

3.2

Summary

In Chapter 2, the reliability and validity of our handheld mechanical 3D US imaging
device were tested by comparing manual FAC volume quantifications against MRI.
Bilateral knee images of 25 healthy volunteers were acquired with MRI and our 3D US
scanner. MRI scans were acquired using a 3.0 Tesla General Electric Healthcare system
with a 3D MERGE acquisition sequence. 3D US scans were acquired using a Canon
Medical Systems Aplio i800 US machine equipped with a 14L5 linear transducer. Two
raters manually segmented the tFAC from both MRI and 3D US after receiving training
from a rheumatologist with advanced diagnostic and interventional musculoskeletal
ultrasonography experience. Each rater repeated segmentations on five cases during
separate sessions to assess intra-rater reliability. 3D US and MRI segmentations were
registered using a semi-automated surface-based registration algorithm. The MRI
segmentations were trimmed to match the same FAC ROI from 3D US to enable direct
volume comparisons. Intra- and inter-rater reliabilities were assessed using ICCs
calculated from the segmentation volumes. Spearman correlation and linear regression
were used to evaluate the relationships between MRI and 3D US tFAC volumes.
MRI intra-rater ICCs were 0.97 (0.79, 1.00) and 0.90 (0.25, 0.99) for each rater, with an
inter-rater ICC of 0.83 (0.48, 0.94). 3D US intra-rater ICCs were 1.00 (0.98, 1.00) and
0.98 (0.84, 1.00) for each rater, with an inter-rater ICC of 0.96 (0.90, 0.98). Spearman
correlation and linear regression revealed a strong correlation ρ = 0.88 (0.75, 0.95) and
regression R2 = 0.85 (0.75, 0.95). These results indicate that 3D US is associated with
excellent intra- and inter-rater reliabilities and strong concurrent validity with MRI when
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quantifying healthy tFAC volume with manual segmentations. 3D US imaging has the
potential to greatly improve feasibility for quantifying knee cartilage volume during
KOA clinical trials and patient care.

3.3

Limitations

This study was conducted on volunteers with healthy knees and not patients diagnosed
with KOA. In diseased patients, the FAC develops surface abnormalities such as fissures,
abrasions, divots, and other irregularities. Therefore, the measurement properties of our
3D US device need to be evaluated in KOA patients before clinical implementation.
Additionally, 3D US imaging possesses a smaller FOV than MRI, making it difficult to
visualize the entire FAC in a single 3D US image. It is possible to visualize the weightbearing femoral condylar cartilage using 3D US with additional acquisitions. However,
variations in the patella position relative to the cartilage surface in MRI compared to 3D
US resulted in difficulties registering condylar cartilage segmentations between
modalities.
Due to the large acoustic impedance mismatch between soft tissue and bone, US imaging
cannot visualize the FAC through the patella and tibia. Therefore, knees were imaged
during maximum flexion with 3D US to reveal the largest possible region of FAC
without obstruction by the tibia. The bore size of MRI scanners cannot accommodate legs
under full knee flexion, making it impossible to acquire MR images of the knee in the
same orientation as 3D US images. The differences in the degree of knee flexion between
MRI and 3D US acquisitions result in variations in the patella position along the trochlear
groove. These variations introduced complications when identifying the intercondylar
notch for registering MRI and 3D US segmentations. However, registering FAC
segmentations between MRI and 3D US is only necessary for validating our 3D US
device against MRI. When using 3D US independently in the clinic and future studies,
multi-modality registrations will not be required.

57

3.4

Future directions

The results of this work highlight the potential of 3D US for use as an objective, imagingbased POC tool to assess KOA status, progression, and response to treatment. In Chapter
2, FAC volume measurements were acquired using our handheld mechanical 3D US
device and validated against MRI in healthy volunteers. A study investigating the
reliability and validity of our 3D US device for quantifying FAC volume in patients
diagnosed with KOA will be conducted to expand beyond healthy volunteers and provide
further evidence for clinical feasibility. Longitudinal studies using 3D US to monitor
FAC volume changes in healthy volunteers and KOA patients should also be conducted
to evaluate 3D US’s sensitivity to cartilage volume changes.
Future studies will also investigate the application of our 3D US device for monitoring
knee synovitis. Synovitis and the resultant pro-inflammatory mediators are essential
components in the pathogenesis of KOA.6,7 Synovitis may also be linked to heightened
pain sensitivity through sensitization and activation of sensory neurons. 8,9 Monitoring
changes in synovial volume with 3D US may provide insight into the complex
relationship between synovitis, pain, and KOA. However, synovitis can cause the
synovium to expand to several times the size of its healthy state, making it difficult to
visualize the entire synovium in a single 3D US image. Furthermore, there is an absence
of rigid anatomical landmarks in the suprapatellar synovium region, making it
challenging to register several images. To address these challenges, we have developed a
counterbalanced POC system that can track the position of 3D US acquisitions in 3D
space. The tracking information enables merging multiple 3D US acquisitions to
visualize the entire suprapatellar synovium in a single image. The POC system features a
multi-jointed arm linkage with electromagnetic encoders at each joint to compute the
position and orientation of our 3D US device using forward kinematics. The tracking
accuracy of the POC system was validated using an external optical tracking system,
demonstrating an overall mean absolute tracking error of 3.08 ± 2.01 mm with no
difference between the two tracking systems (p = 0.965).10 Future work will decrease the
POC system’s tracking error and test the image registration capabilities using volumetric
agar phantoms before imaging volunteers and KOA patients.
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Another direction for future work is to develop automatic cartilage segmentation
algorithms with deep learning. Several studies have investigated the application of deep
learning for automatic knee cartilage segmentations.11,12,13 Manual 3D US cartilage
segmentations are time-consuming and subject to operator dependencies. Automatic
segmentation will enable clinicians to measure FAC volume directly at the patient’s
bedside using 3D US. Future studies will also investigate monitoring synovitis using 3D
US and deep learning.

3.5

Conclusion

In conclusion, this thesis investigates applying a handheld mechanical 3D US device for
monitoring KOA progression and response to treatment at the patient’s bedside. The
study described in this thesis demonstrates that 3D US FAC volume measurements are
associated with excellent reliability and strong concurrent validity with the current
clinical standard of MRI. 3D US imaging is a promising, widely accessible imaging
modality for POC assessments of KOA and will enable clinicians and researchers to
obtain valuable information without added discomfort to patients.
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